60 Degrees Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 2.13, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. 60 Degrees Pharmaceuticals Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 171 days, from 165 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 505 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3284, from overall ranking in the first quarter 2026 at 3782.

What is Receivable Turnover Ratio?
What is 60 Degrees Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SXTP Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	92.22 %	-31.21 %	4.71 %	38.48 %	-0.46 %
Y / Y Revenue Change	106.04 %	-0.92 %	25.58 %	250.16 %	-4.54 %
Receivable Turnover Ratio (TTM)	2.13	2.21	2.04	1.94	1.44
SXTP's Total Ranking	# 3284	# 3782	# 3448	# 3540	# 3576
Accounts Receivable average collection period days	171	165	178	188	254
Seq. Receivable Change	68.84 %	-34.1 %	-24.39 %	128.49 %	-39.57 %
Seq. Revenue Change	28.26 %	-46.57 %	-30.67 %	333.7 %	-38.33 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 164
Healthcare Sector	# 506
Overall Market	# 3284

Receivable Turnover Ratio Statistics
High	Average	Low
2.85	2.06	1.6
(Dec 31 2023)		(Mar 31 2025)

News about 60 Degrees Pharmaceuticals Inc Receivables Turnover Ratios

60 Degrees Pharmaceuticals Inc. Paves the Way for Improved Malaria Prevention with ARAKODA Promotional Pilot

In a significant development for global health and pharmaceutical marketing, 60 Degrees Pharmaceuticals Inc. (NASDAQ: SXTP) has announced a promotional pilot program aimed at increasing awareness around ARAKODA, its innovative antimalarial treatment. This strategic move comes ahead of an anticipated expanded launch of the drug across the United States, targeting both prescribers and patients in a bid to improve malaria prevention practices.ARAOKDA (generic name: apsa (UK-PHM) is a breakthrough in the pharmacological landscape, providing a new avenue for malaria prophylaxis, particularly in high-risk regions. The drug employs a unique mechanism of action that enhances its effectiveness against Plasmodium parasites, which are responsible for the malaria infection. With growing concerns about malaria resurgence in certain areas of the United States, primarily due to increased travel and changing climate conditions, effective preventive measures are more crucial than ever.

SXTP Company Profile • Back to SXTP Efficiency Comparisons • Compare SXTP Receivables Turnover Ratio to its Competitors

Financial Statements
60 Degrees Pharmaceuticals Inc 's Accounts Receivable	$ 1 Millions	Visit SXTP's Balance sheet
60 Degrees Pharmaceuticals Inc 's Sales TTM	$ 1 Millions	Visit SXTP's Income Statement
Sources of SXTP's Revenues		Visit SXTP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SXTP's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SXTP's Growth Rates	SXTP's Roa	SXTP's Inventory Turnover Ratio	SXTP's Dividend Comparisons
SXTP's Profitability Ratios	SXTP's Roi	SXTP's Asset Turnover Ratio	SXTP's Dividend Growth
SXTP's Valuation Ratios	SXTP's Roe	SXTP's Financial Strength Ratios	SXTP's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Igc Pharma Inc	5.36	$ 1.101 Millions	$ 0.206 Millions
Strata Critical Medical Inc	5.27	$ 211.642 Millions	$ 40.126 Millions
Elutia Inc	5.16	$ 11.353 Millions	$ 2.198 Millions
West Pharmaceutical Services Inc	5.12	$ 3,326.900 Millions	$ 649.250 Millions
Repligen Corp	5.09	$ 785.101 Millions	$ 154.205 Millions
Progyny Inc	5.09	$ 1,311.298 Millions	$ 257.570 Millions
Pfizer Inc	4.98	$ 63,696.000 Millions	$ 12,802.250 Millions
Agilent Technologies inc	4.96	$ 7,372.000 Millions	$ 1,487.500 Millions
Plus Therapeutics Inc	4.90	$ 4.203 Millions	$ 0.858 Millions
Ligand Pharmaceuticals Incorporated	4.77	$ 290.542 Millions	$ 60.966 Millions
Personalis Inc	4.75	$ 69.669 Millions	$ 14.676 Millions
Bausch and Lomb Corp	4.65	$ 5,324.000 Millions	$ 1,144.000 Millions
Davita Inc	4.64	$ 14,009.646 Millions	$ 3,018.719 Millions
Orasure Technologies Inc	4.62	$ 111.978 Millions	$ 24.227 Millions
Yunhong Green Cti Ltd	4.58	$ 20.662 Millions	$ 4.513 Millions
Bionexus Gene Lab Corp	4.48	$ 3.127 Millions	$ 0.697 Millions
Bellevue Life Sciences Acquisition Corp	4.47	$ 1.809 Millions	$ 0.404 Millions
Vaso Corporation	4.44	$ 80.220 Millions	$ 18.048 Millions
Neurocrine Biosciences Inc	4.40	$ 3,373.900 Millions	$ 767.475 Millions
Organon and Co	4.31	$ 6,139.000 Millions	$ 1,422.750 Millions
Alkermes Plc	4.30	$ 1,667.652 Millions	$ 388.132 Millions
Glaukos Corp	4.29	$ 500.031 Millions	$ 116.471 Millions
Inspiremd Inc	4.12	$ 10.502 Millions	$ 2.550 Millions
Medinotec Inc	4.07	$ 10.247 Millions	$ 2.519 Millions
Pelthos Therapeutics Inc	4.03	$ 43.304 Millions	$ 10.757 Millions
Gyre Therapeutics Inc	4.02	$ 119.383 Millions	$ 29.697 Millions
Vaxart Inc	4.02	$ 243.064 Millions	$ 60.514 Millions
Bridgebio Pharma Inc	3.99	$ 713.069 Millions	$ 178.918 Millions
Biomerica Inc	3.97	$ 4.453 Millions	$ 1.121 Millions
Retractable Technologies Inc	3.95	$ 33.488 Millions	$ 8.484 Millions

Date modified: 2026-08-17T17:24:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.